Abstract 4663: Human papillomavirus circulating tumor DNA for risk stratification in cervical cancer
Sign Up to like & getrecommendations! Published in 2025 at "Cancer Research"
DOI: 10.1158/1538-7445.am2025-4663
Abstract: Human papillomavirus (HPV) DNA is detectable in the peripheral blood plasma from patients with locally advanced and metastatic cervical cancer. Levels of HPV circulating tumor DNA (ctDNA) in pretreatment plasma have weak associations with prognosis,… read more here.
Keywords: cancer; cervical cancer; locally advanced; ctdna ... See more keywords
Prognostic impact of residual HPV ctDNA detection after chemoradiotherapy for anal canal carcinoma.
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2018.36.15_suppl.3565
Abstract: 3565Background: Chemoradiotherapy (CRT) is the current standard of care for patients diagnosed with locally advanced anal squamous cell carcinoma (ASCC), but some patients will present a local and/... read more here.
Keywords: carcinoma; chemoradiotherapy; residual hpv; hpv ctdna ... See more keywords
Time dependency for HPV ctDNA detection as a prognostic biomarker for anal cancer.
Sign Up to like & getrecommendations! Published in 2024 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2024.42.16_suppl.3513
Abstract: 3513 Background: Prior HPV infection is associated with > 90% of anal cancers, a malignancy with rising incidence in the United States. Standard treatment for localized anal cancer is concurrent chemoradiation (cRT). While detection of… read more here.
Keywords: detection; hpv; anal cancer; hpv ctdna ... See more keywords